Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Altria

TLRY stock could end up as a force in the cannabis sector, but investors' fears and hesitation and legalization remain unchanged. The post Tilray Stock Is Not Very Different Since Its Altria Merger appeared first on InvestorPlace.

Tilray Stock Is Not Very Different Since Its Altria Merger

Aurora Cannabis

Canopy Growth

Cronos Group

The cannabis industry is faced with two main objectives: Finding the right product to competitively grow and then finding the right place to actually set up operations. Sale-leaseback options are a financing tool cannabis companies are increasingly using in their pursuit of non-traditional financing.

Sale/Lease Buyback Model - Why It's the Hottest Funding Method for Cannabis Properties Now and Why It May Soon Not Be So Hot…

Could These Marijuana Stocks Deliver Gains In May? The post Are These The Best Canadian Marijuana Stocks To Buy? 2 To Watch Right Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Are These The Best Canadian Marijuana Stocks To Buy? 2 To Watch Right Now

SNDL Inc.

Canadian Pot Stocks With Potential In May The post Are Canadian Cannabis Stocks Ready For A Rebound? 3 To Add To Your Watchlist Next Week appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Are Canadian Cannabis Stocks Ready For A Rebound? 3 To Add To Your Watchlist Next Week

Li Auto Inc.

XPeng

Zoom Video

The Swiss National Bank initiated a position in Chinsese electric-vehicle maker Li Auto, and bought more shares of peer XPeng. The bank also bought more Zoom Video shares, and marijuana stock Tilray.

Swiss Central Bank Bought Li Auto, XPeng, Zoom, and This Marijuana Stock

The shares of Tilray Inc (NASDAQ: TLRY) have received a price target of $20 by Cowen. These are the details.

Tilray (TLRY) Stock: $20 Target By Cowen

Curaleaf Holdings, Inc.

Innovative Industrial Properties

Akerna Corp

Amplify Alternative Harvest ETF

Cambria Cannabis ETF

AdvisorShares Pure Cannabis ETF 

Canadian marijuana stocks have fallen from their February highs. But one player in the industry got a lot bigger after a merger deal.

Are Any Canadian Marijuana Stocks Good Buys As Earnings Disappoint?

Tilray was named to Time.com's 2021 Time100 Most Influential Companies list days before merger. Is that a reason to buy TLRY stock?

Despite a Rough Week, Tilray Is Still a Better Investment Now Than a Year Ago

NEW YORK & LEAMINGTON, Ontario--(BUSINESS WIRE)--Tilray, Inc. (“Tilray”) (NASDAQ | TSX: TLRY) announced that the Company will participate in the BMO Capital Markets 16th Annual Farm to Market Conference on Wednesday, May 19, 2021. The presentation will begin at 8:40 AM ET. Please refer to the Investors section of the Company's website at www.tilray.com under “Events and Presentations” for webcast information. About Tilray Tilray, Inc. is a leading global cannabis-lifestyle and consumer packaged

Tilray to Participate in BMO Capital Markets Investor Conference

It's too early to tell whether its recent combination with Aphria will succeed, but consider TLRY stock a cautious buy after its sell-off. The post Beaten-Down Tilray Stock May be Worth the Risk appeared first on InvestorPlace.

Beaten-Down Tilray Stock May be Worth the Risk

Investors are hoping that Tilray can finally turn itself around now that it is officially the biggest Canadian cannabis producer following the completion of its merger with former rival Aphria. Until then, keep TLRY stock on your watchlist.

Post-Merger Tilray Stock Is One To Keep On Your Watchlist for Now

Some view TLRY stock as an upside opportunity due to technical reasons but the fundamentals suggest a cautionary approach. The post Tilray's Fundamentals Aren't Very Solid appeared first on InvestorPlace.

Tilray's Fundamentals Aren't Very Solid

These Marijuana Stocks Are Starting To Reach Better Market Levels The post 2 Cannabis Stocks To Watch Before The End Of The Week appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

2 Cannabis Stocks To Watch Before The End Of The Week

Low volatility weed stocks that are best positioned to benefit from industry tailwinds and potential cannabis legalization at federal level. The post 4 of the Least Volatile Weed Stocks appeared first on InvestorPlace.

4 of the Least Volatile Weed Stocks

Aphria

The global company has many different paths for growth moving forward.

What's Next for Tilray Now That Its Merger With Aphria Is Complete?

Tilray, Inc. (TLRY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Tilray, Inc. (TLRY) Moves 14.4% Higher: Will This Strength Last?

Trulieve Cannabis Corp.

These Cannabis Companies Are Making Big Waves In The Industry The post These Marijuana Companies Are Now The Biggest In The World appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

These Marijuana Companies Are Now The Biggest In The World

The cannabis company released results of its last quarter before the merger with Aphria.

Tilray Didn't Announce Its Last Quarter. The Numbers Weren't Great.

Tilray, Inc. (TLRY) delivered earnings and revenue surprises of -90.00% and -22.38%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Tilray, Inc. (TLRY) Reports Q1 Loss, Misses Revenue Estimates

Freeport-McMoRan

Horizon Pharma

Zillow

As investors were so righteously reminded on Friday, many of the day-to-day Wall Street prognostications and strategy calls are almost always “best guesses” or data-based “assumptions.

Why 4 Jefferies Top Growth Stocks to Buy May Be Perfect Ideas Now

The stock price of Tilray Inc (NASDAQ: TLRY) increased from $14.15 to $16.81 on Friday. This is why it happened.

TLRY Stock: 14.35% Increase Explanation

Disappointing earnings from Aphria played a large role in Tilray's move.

Why Tilray Stock Dropped in April

Analysts are high on the cannabis company's growth prospects.

Here's Why Tilray Stock Is Surging

Datadog

The lagging index got a nice boost to finish the week on Friday.

Tilray, Datadog Give Nasdaq Investors Something to Smile About

Tilray Inc. (NASDAQ:TLRY) shares were trading higher Friday after a Jefferies analyst double upgraded the stock. The stock was double upgraded from Underperform to Buy and the price target was raised from $4.77 to $23.

News for Tilray Brands Stock (TLRY)